Bill Search

  • Introduced
    Jul 30, 2021
  • Passed House
  • Passed Senate
  • Signed into Law
HB 1741
Pennsylvania House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.
Last Action See all actions
House • Jun 14, 2022: Re-committed to APPROPRIATIONS
Do you support this bill?
Yay Nay

Official Summary/Bill Text

Comments on HB 1741

Matthew Eby wrote 9 months ago

Healthcare delivery requires a partnership between patient and doctor; let’s not harm that relationship. Perhaps a patient signs a waiver when being prescribed off-label drugs. We can balance freedom of choice with protection from harm.

Tweets

Whip Lists

Sponsors
Votes
YES: 111

NO: 89

EXCUSED: 2

Actions
  • Jun 14, 2022 | House
    • PN 3241 Second consideration, with amendments
    • Re-committed to APPROPRIATIONS
  • Jun 08, 2022 | House
    • Removed from table
  • Jun 07, 2022 | House
    • Removed from table
    • Laid on the table
  • Feb 07, 2022 | House
    • PN 2713 Reported as amended
    • First consideration
    • Laid on the table
  • Jul 30, 2021 | House
    • PN 1972 Referred to HEALTH
Documents
Looks like we don't have any documents available at this moment.